Shandong Weigao Group
1066.HK
HKD5.45 -1.27%
Exchange: HKSE | Sector: Healthcare | Industry: Medical Instruments Supplies
Q3 2024
Published: Sep 30, 2024

Earnings Highlights

  • Revenue of $3.23B up 1.9% year-over-year
  • EPS of $0.10 increased by 14.6% from previous year
  • Gross margin of 49.0%
  • Net income of 479.56M
  • "N/A" - N/A
1066.HK
Company 1066.HK

Executive Summary

Shandong Weigao delivered a resilient QQ3 2024 performance with revenue of 3,225.69 million CNY, up 1.89% year over year but down 2.78% quarter over quarter. The quarter’s gross profit reached 1,579.61 million CNY, yielding a gross margin of 48.97%, a modest year-over-year improvement (up 3.00%) but a sequential decline of 6.43% driven by mix and cost dynamics. Operating income rose 25.76% year over year to 504.91 million CNY, yet declined 20.05% QoQ, resulting in an operating margin of 15.65%. Net income was 479.56 million CNY, up 19.27% from the prior year but down 13.40% from the prior quarter, with an implied net margin of 14.87%. Earnings per share (basic and diluted) stood at 0.10 CNY.

Key Performance Indicators

Revenue
Increasing
3.23B
QoQ: -2.78% | YoY: 1.89%
Gross Profit
Increasing
1.58B
48.97% margin
QoQ: -6.43% | YoY: 3.00%
Operating Income
Increasing
504.91M
QoQ: -20.05% | YoY: 25.76%
Net Income
Increasing
479.56M
QoQ: -13.40% | YoY: 19.27%
EPS
Increasing
0.10
QoQ: -16.67% | YoY: 14.55%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 3,322.02 0.11 +106.0% View
Q1 2025 3,322.02 0.11 +0.1% View
Q4 2024 3,225.69 0.10 +1.9% View
Q3 2024 3,225.69 0.10 +1.9% View